Jazz Pharmaceuticals plc
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $592.4M | $582.7M | $9.7M | $98.8M |
| FY2017 | $693.1M | $664.1M | $29.0M | $106.9M |
| FY2018 | $798.9M | $778.5M | $20.4M | $102.4M |
| FY2019 | $776.4M | $736.3M | $40.1M | $110.6M |
| FY2020 | $899.6M | $884.6M | $15.0M | $121.0M |
| FY2021 | $778.5M | $750.9M | $27.6M | $189.0M |
| FY2022 | $1.27B | $1.24B | $29.0M | $222.0M |
| FY2023 | $1.09B | $1.07B | $24.0M | $226.8M |
| FY2024 | $1.40B | $1.36B | $38.1M | $248.0M |
| FY2025 | $1.36B | $1.30B | $58.8M | $291.1M |